Reference 2018-665

REF:           2018-665

Subject:       Dermatitis treatments and patient numbers

 

Request:

Question 1

How many patients are currently (within the last 3 months) being treated for moderate or severe atopic dermatitis (also known as eczema) ?

Question 1b

Of these treated patients how many are paediatric ?

Question 2

How many patients are currently being treated for moderate or severe atopic dermatitis (also known as eczema) with the following drugs ?

Drug Name Total
Acitretin
Alitretinoin
Pimecrolimus
Tacrolimus
Dupixent (Dupilumab)
Phototherapy including with ultraviolet (UVB) radiation or psoralen ultraviolet A (PUVA)
Potent Topical Corticosteroids (creams or ointments) total
Amcinonide 0.05% (Cyclocort)
Betamethasone diproprionate 0.05% (Diprosone)
Betamethasone valerate
Clobetasol proionate
Desoximetasone 0.25% (Topicort)
Diflucortolone valerate
Fluocinonide 0.05% (Lidex)
Fluticasone proprionate 0.005% (Cutivate)
Halcinonide 0.05% (Halog)
Mometasone furoate 0.1% (Elocon ointment)
Triamcinalone acetonide 0.5% (Kenalog, Aristocrt cream)
Betamethasone dipropionate 0.25% (Diprolene)
Clobetasol dipropionate 0.05% (Temovate)
Diflorasone diacetate 0.05% (Psorcon)
Halbetasol proprionate 0.05% (Ultravate)
Immunosppressive therapies total
Azathioprine
Ciclosporin
Methotrexate

 

Question 3

Does your Trust use any of the following to treat severe dermatitis ? If so how many patients in the past 3 months ?

Drug Name Total
Etanercept
Infliximab
Adalimumab
Ustekinumab

 

 

Response:

Please find information attached.

2018-665 – FOI Request – Dermatitis treatments and patient numbers [12 kb] MS Excel